Cold Plasma Risks: Who Should Avoid Treatment?

Who Should Not Have Cold Plasma

Cold plasma therapy is an emerging treatment approach used mainly in wound care, dermatology, and some aesthetic settings, but it is not automatically suitable for everyone. The safest answer is that people with implanted electronic devices, pregnancy or breastfeeding, active cancer, severe systemic illness, uncontrolled infection, poor circulation requiring urgent vascular treatment, or fragile skin conditions should not proceed unless a qualified clinician has specifically cleared them. This guide explains the main plasma therapy risks, common cold plasma side effects, and the treatment risk factors to review before booking or accepting care.

Who should avoid cold plasma therapy?

People should avoid or delay cold plasma therapy when there is a realistic chance that the device, the treatment area, or their medical condition could make the procedure unsafe or difficult to monitor. Current reviews note that no universal formal contraindication list has been established for cold atmospheric plasma, but clinical studies often exclude higher-risk groups such as people with pacemakers or implantable defibrillators, pregnant or breastfeeding patients, active cancer, dialysis-dependent renal failure, systemic infection, severe chronic disease, and certain circulation problems; that means safety is not well proven for those groups.

That distinction matters. “Not proven unsafe” is not the same as “proven safe.” Cold plasma can be promising when used with the right device, indication, dosing, and supervision, but it should not be treated like a casual spa add-on or a do-it-yourself skin gadget. If you are asking, “Who Should Not Have Cold Plasma?” the practical answer is: anyone with a significant health condition, implanted device, active skin problem, uncertain diagnosis, or unclear treatment goal should get medical advice first.

A cautious screening conversation is especially important because the term “cold plasma” is used in different ways. In medical wound care, cold atmospheric plasma may be applied to wounds to reduce microbes and support healing. In aesthetic settings, “plasma pens” or arc-based devices may intentionally injure superficial skin to affect lesions or appearance, and the risk profile can be different. The name sounds similar, but the device type, tissue target, operator training, and safety evidence are not interchangeable.

Cold plasma therapy in plain language

Cold plasma is an ionized gas containing reactive species, charged particles, and other energetic components that can interact with microbes and skin or wound tissue without the high heat associated with surgical cautery. In wound care research, it is often called cold atmospheric plasma or CAP, and it has been studied as an add-on to standard care for chronic wounds, diabetic foot ulcers, venous leg ulcers, burns, and some dermatologic uses. Trials have reported encouraging healing or antimicrobial effects in selected patients, but those studies are controlled settings, not proof that every person or every device use is appropriate.

The intended effect depends on dose and context. Short, controlled exposure may influence microbial load and tissue signaling, while excessive intensity, prolonged exposure, or treatment on the wrong tissue may increase the chance of irritation, delayed healing, or tissue damage. A recent review emphasized that treatment should take account of the patient’s condition, lesion type, and medical recommendations, and that excessive treatment can move from helpful stimulation toward impaired healing or necrosis.

It is also important to separate cold atmospheric plasma from platelet-rich plasma, blood plasma products, laser therapy, radiofrequency procedures, and cryotherapy. These are different technologies with different risks. If a clinic advertises “plasma” without specifying the device, the intended use, the operator’s training, and whether the treatment is medical or cosmetic, that uncertainty itself is a reason to pause.

Main groups who may not be good candidates

Not every item below is an absolute ban in every country, clinic, or device manual. Instead, these are common red flags that should trigger postponement, referral, or formal clearance from an appropriate healthcare professional. The more red flags a person has, the stronger the case for avoiding treatment unless it is being delivered in a properly supervised medical setting.

People with pacemakers, implantable defibrillators, or active electronic implants

People with implanted cardiac devices should be especially cautious. Clinical cold plasma studies have frequently excluded patients with pacemakers or implantable cardioverter defibrillators, leaving limited evidence for safety in these groups.

The concern is not simply “electricity” in a vague sense. Plasma devices are powered instruments that generate electrical fields, reactive species, and sometimes arcs or jets near tissue. For someone with a device that controls or monitors heart rhythm, even a low probability of interference may be unacceptable without device-specific guidance. This is particularly important if treatment is near the chest, upper back, neck, or any area close to implanted leads.

If you have an implanted neurostimulator, insulin pump, cochlear implant, deep brain stimulator, or other active electronic device, take the same cautious approach. Do not rely on a spa consent form as clearance. Ask the prescribing specialist or device clinic whether the specific cold plasma device and treatment site are acceptable.

Pregnant or breastfeeding patients

Pregnant and breastfeeding patients are usually poor candidates for elective cold plasma treatment because they are commonly excluded from clinical research. Reviews of cold atmospheric plasma in wound care note that pregnancy and breastfeeding are among the groups often left out of trials, which means safety evidence is insufficient rather than reassuring.

That does not mean a single exposure is known to cause harm. It means the responsible standard is caution, especially for cosmetic, anti-aging, scar, or non-urgent skin procedures. During pregnancy, skin sensitivity, pigmentation tendencies, blood flow, immune responses, and wound healing can change; adding an emerging device treatment without a clear medical need is rarely worth it.

If cold plasma is being considered for a serious wound during pregnancy or while breastfeeding, the decision should be made by the treating medical team, not by a cosmetic provider. The question becomes whether the expected benefit outweighs the unknowns for that specific patient and wound.

People with active cancer or unclear suspicious lesions

People with active cancer should not pursue cold plasma therapy casually, especially over or near a tumor, suspicious lesion, surgical cancer site, or unexplained wound. Cold atmospheric plasma is being researched in oncology, including possible cancer-related applications, but that research does not make general aesthetic or wound treatment automatically safe for cancer patients.

Suspicious skin lesions need diagnosis before device treatment. A mole that is changing, a non-healing sore, a bleeding patch, or a crusted growth should be assessed by a qualified clinician before it is destroyed, resurfaced, or treated cosmetically. Device treatment can alter the appearance of tissue and may delay proper diagnosis if used before biopsy or dermatology evaluation.

People receiving chemotherapy, immunotherapy, radiation therapy, or cancer surgery follow-up should ask their oncology team before considering cold plasma. Their skin, immune function, clotting status, and healing capacity may be different from those of healthy trial participants.

People who are immunosuppressed or medically unstable

Immunosuppressed patients need individualized medical clearance. This includes people taking high-dose corticosteroids, biologic immune therapies, transplant medications, some chemotherapy drugs, or other medications that reduce immune response. Reviews identify immunosuppressive therapy among common exclusion factors in cold plasma studies, so routine safety assumptions should not be stretched to this group.

The issue is not only infection risk. Immunosuppression can change how skin reacts after controlled injury or antimicrobial treatment. A small irritation in one person may become prolonged inflammation, delayed healing, or secondary infection in someone else.

Medically unstable patients should also delay non-urgent treatment. If someone has uncontrolled blood sugar, unstable heart disease, severe anemia, recent hospitalization, fever, unexplained swelling, or worsening pain, the priority is medical stabilization and diagnosis. Cold plasma should not be used to bypass standard care.

People with severe circulation problems or wounds needing urgent vascular care

Cold plasma may be studied for certain chronic wounds, but it is not a substitute for blood flow. People with signs of severe peripheral arterial disease, limb ischemia, or wounds that may require revascularization need vascular assessment first. Wound care studies often exclude patients who require revascularization because healing cannot be expected if tissue is not receiving adequate oxygen and nutrients.

Warning signs include a foot or toe that is cold, pale, blue, black, increasingly painful, numb, or associated with rapidly worsening skin breakdown. In those situations, the risk is not merely that cold plasma will fail. The larger risk is losing time while a limb-threatening circulation problem progresses.

For venous leg ulcers, diabetic foot ulcers, pressure injuries, and burns, cold plasma should be considered only as part of a complete care plan. That plan may include debridement, compression, offloading, infection control, vascular testing, blood sugar management, dressings, and follow-up.

People with systemic infection or spreading local infection

A wound that is red, hot, swollen, increasingly painful, draining pus, producing a foul odor, or accompanied by fever needs medical assessment. Cold plasma has antimicrobial effects under certain settings, and some trials have studied microbial reduction, but it should not be used as a stand-alone replacement for urgent infection care.

Spreading infection can become serious quickly. Red streaking, chills, confusion, rapid heart rate, low blood pressure, or severe pain are reasons to seek urgent care, not a device appointment. For people with diabetes, immune compromise, vascular disease, or kidney disease, the threshold for medical review should be even lower.

A clinician may still use cold plasma as an adjunct in a structured wound program. The key word is adjunct. It should sit beside standard medical treatment, not replace diagnosis, antibiotics when indicated, drainage, debridement, or surgical care.

People with dialysis-dependent kidney failure or severe chronic disease

Patients with renal failure requiring dialysis and people with severe chronic internal diseases have often been excluded from cold atmospheric plasma studies. That means routine claims about tolerability may not apply to them.

These patients may have fragile skin, fluid shifts, altered immunity, anemia, vascular calcification, neuropathy, medication interactions, and higher infection risk. A treatment that seems minor in a wellness setting may be more consequential in a medically complex person. If cold plasma is being considered for a wound, it should be coordinated with the wound care clinician, nephrologist, primary physician, or relevant specialist.

The same principle applies to people with advanced liver disease, poorly controlled autoimmune disease, unstable cardiopulmonary disease, or severe malnutrition. The more complex the body’s healing environment, the less appropriate it is to treat cold plasma as a routine service.

People with fragile, reactive, or actively inflamed skin

People with very reactive skin should be cautious, especially when cold plasma is offered for cosmetic reasons. Cold plasma side effects reported in wound and dermatology studies include discomfort such as stinging, prickling, cramping, pain-related sensations, erythema, eczema-like reactions, maceration, irritation, bleeding, and scar-related events, although serious device-related events were not commonly attributed in the cited trials.

Active dermatitis, uncontrolled eczema, psoriasis flare, rosacea flare, open infection, recent sunburn, chemical burn, or a fresh peel can make skin less predictable. So can recent isotretinoin use, aggressive exfoliation, or multiple procedures performed close together. Even if cold plasma is “non-thermal” in a medical sense, the skin can still react to device exposure.

People with a history of keloids, hypertrophic scarring, post-inflammatory hyperpigmentation, or poor wound healing should ask whether the expected benefit is worth the risk. This is especially important for darker skin tones when the procedure is intended to create controlled surface injury for aesthetic remodeling.

People seeking treatment from unqualified providers or unclear devices

One of the most important treatment risk factors is the setting itself. A trained wound clinician using a regulated device for a defined wound indication is very different from an unlicensed provider using a generic plasma pen for broad cosmetic claims.

Be skeptical of claims that one device can safely treat wrinkles, infections, scars, acne, hair loss, wounds, moles, skin tags, and “collagen loss” with no downtime and no risks. Real medical devices have specific intended uses, instructions, warnings, and operator requirements. If those details are missing, the risk assessment is incomplete.

Common cold plasma side effects

Most reported cold plasma side effects in clinical studies are local and temporary, but they still matter. In a randomized trial of diabetic foot ulcers, expected adverse events included scar formation, skin irritation, bleeding, and proliferation, and adverse events were tracked carefully across both treatment and placebo groups.

In a venous leg ulcer trial, treatment-related events were mainly pain sensations described as stinging, prickling, or cramping during application; other possibly or likely related events included eczema, erythema, and wound maceration. The study reported serious adverse events, but none were considered related to the device.

For a patient, the practical side effect checklist includes:

• During treatment: warmth, prickling, stinging, cramping, mild pain, or discomfort.

• After treatment: redness, irritation, dryness, tenderness, swelling, crusting, or temporary sensitivity.

• Wound-specific concerns: bleeding, maceration, changes in drainage, delayed improvement, or increased pain.

• Cosmetic-procedure concerns: pigment change, scarring, prolonged redness, infection, or uneven texture.

• Urgent warning signs: fever, spreading redness, pus, severe pain, blackening tissue, shortness of breath, chest symptoms, or symptoms suggesting device interference in someone with an implant.

Side effects are more concerning when the provider cannot explain what is expected, what is abnormal, and when to seek help. Before any treatment, you should know how the area should look the same day, the next day, and during healing.

Why do treatment risk factors matter so much?

Treatment risk factors matter because cold plasma outcomes depend on the device, dose, treatment area, medical condition, and aftercare—not just the broad label “cold plasma.” A controlled trial result in selected wound patients does not automatically apply to a pregnant patient, a person with a pacemaker, a cosmetic mole-removal client, or someone with an infected diabetic foot wound.

The most important risk factors fall into five categories. First, there are patient factors: pregnancy, implanted devices, cancer history, immune status, circulation, diabetes control, kidney disease, medications, and scarring tendency. Second, there are lesion factors: whether the target is a clean wound, infected wound, suspicious growth, inflamed rash, scar, wrinkle, or ulcer.

Third, there are device factors. Cold atmospheric plasma jets, dielectric barrier discharge devices, and plasma pens are not identical. Fourth, there are operator factors: training, medical oversight, infection control, emergency protocols, and ability to recognize when not to treat. Fifth, there are aftercare factors, including wound dressings, compression, offloading, sun protection, and follow-up.

A good screening process should cover all five. If the only screening question is “Do you want to book today?” that is a warning sign.

Medical cold plasma and cosmetic plasma procedures are not the same

Cold plasma in medical literature is often discussed as an adjunct for wounds, microbial reduction, dermatology, and investigational cancer-related applications. Cosmetic plasma services may involve devices marketed for skin tightening, lesion removal, resurfacing, or fibroblast-style treatments. These uses can overlap in language but differ in intent: one may aim to support healing, while another intentionally creates controlled injury to change appearance.

The regulatory picture also varies by device and intended use.

A practical pre-treatment screening checklist

Use this checklist before any cold plasma appointment, whether it is for wound care, dermatology, or aesthetics. A responsible provider should welcome these questions.

• Confirm the goal. Is the treatment for wound healing support, microbial reduction, skin lesion destruction, scar care, texture improvement, or another purpose?

• Identify the device. What is the exact device name, manufacturer, and intended use?

• Check medical exclusions. Tell the provider about pacemakers, defibrillators, implants, pregnancy, breastfeeding, cancer, kidney disease, immune suppression, diabetes, vascular disease, and active infection.

• Review the treatment area. Has any suspicious lesion been medically assessed? Is the skin inflamed, infected, sunburned, or recently treated?

• Ask about alternatives. Would standard wound care, dermatology evaluation, biopsy, compression, offloading, medication, or surgery be more appropriate first?

• Clarify expected side effects. What sensations and skin changes are normal, and how long should they last?

• Plan aftercare. What dressings, skincare, activity limits, sun protection, or follow-up visits are required?

• Know when to seek help. Ask for written instructions covering fever, spreading redness, worsening pain, bleeding, drainage, burns, or signs of poor healing.

If the provider cannot answer these questions clearly, the safest decision is to postpone. Good care includes saying no when the risk profile is uncertain.

Situations where treatment should usually be delayed

Some people are not permanently ineligible; they simply need to wait. Delay treatment if you have a fever, a new infection, an unexplained rash, recent sunburn, a fresh cosmetic procedure, or a wound that has suddenly worsened. Delay if you started a medication that affects immunity, bleeding, or healing and have not discussed it with your clinician.

You should also delay if the diagnosis is uncertain. A non-healing wound may reflect pressure, diabetes, venous disease, arterial disease, infection, autoimmune disease, or cancer. Treating the surface without understanding the cause can make the care plan look active while the real problem remains untreated.

For cosmetic procedures, delay before major life events. Even mild redness, crusting, pigmentation, or irritation can last longer than expected, particularly if the device is used aggressively or aftercare is poor. A cautious timeline protects both your skin and your expectations.

Questions to ask a provider before cold plasma therapy

A short consultation can reveal a lot about safety.

Consider asking:

• Am I a suitable candidate based on my medical history? The provider should ask follow-up questions rather than give an instant yes.

• Is this device appropriate for my exact condition? A general claim about plasma technology is not enough.

• What evidence supports this use? The answer should distinguish strong evidence, early research, and cosmetic experience.

• What are the realistic benefits? Be wary of promises of guaranteed healing, permanent tightening, or risk-free results.

• What are the most likely side effects for my skin or wound? The answer should be specific to your treatment area.

• Who handles complications? There should be a clear pathway for medical review if pain, infection, burns, or delayed healing occur.

For wound patients, ask how cold plasma fits into the wider care plan. If compression, offloading, vascular assessment, pressure relief, blood sugar management, or debridement is needed, cold plasma should not distract from those foundations.

How should you decide whether cold plasma is worth it?

Decide by weighing the reason for treatment, the quality of evidence for that use, your personal risk factors, and the qualifications of the provider. For a difficult wound being managed by a medical team, cold plasma may be considered as an adjunct when standard care is also in place; for an elective cosmetic treatment in a higher-risk person, the threshold should be much higher.

A simple decision framework can help:

The safest choice is not always “never.” It is often “not yet,” “not in this setting,” or “not without medical clearance.” That kind of caution is not fear; it is proper risk management.

Key takeaways

Cold plasma therapy can be promising, but it is still a device-based intervention with real screening requirements. The people most likely to need caution are those with implanted electronic devices, pregnancy or breastfeeding, active cancer, immune suppression, serious chronic disease, dialysis-dependent kidney failure, poor circulation, systemic infection, suspicious lesions, fragile skin, or a history of abnormal scarring.

The most common cold plasma side effects reported in studies are local sensations and skin or wound reactions, such as stinging, prickling, pain, irritation, redness, eczema-like changes, maceration, bleeding, or scarring-related events. Serious device-related events have not been prominent in several clinical studies, but those studies were conducted in selected patients under defined protocols.

Before treatment, ask what device is being used, what it is intended to treat, what evidence supports that use, what risk factors apply to you, and what aftercare is required. If your provider cannot give clear answers, or if you fall into a higher-risk group, do not rush. Cold plasma is safest when it is matched to the right patient, the right indication, the right device, and the right level of clinical supervision.

Ready to offer cold plasma treatments your clients will love? Explore the Wikbeauty Cold Plasma Machine and find the right system for your spa or home. Shop now at wikbeauty.com, or contact our team for expert advice and a quote today.

Explore Product: Cold Plasma Machine